Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00389
|
|||||
| Drug Name |
Methylphenidate
|
|||||
| Synonyms |
2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester; 2-Piperidineacetic acid, alpha-phenyl-, methyl ester; Alpha-Phenyl-2-piperidineacetic acid methyl ester; Alpha-Phenyl-alpha-(2-piperidyl)acetic acid methyl ester; Attenta (TN); Biphentin (TN); C 4311; Calocain; Centedein; Centedrin; Centredin; Concerta; Concerta (TN); D-methylphenidate HCl; Daytrana; Daytrana (TN); Equasym (TN); METHYLPHENIDATE (SEE ALSO: METHYLPHENIDATE HYDROCHLORIDE, CAS 298-59-9, NTPNO 10266-R); Meridil; Metadate; Metadate CD; Metadate ER; Metadate ER (TN); MethyPatch; Methyl (2-phenyl-2-(2-piperidyl)acetate); Methyl 2-phenyl-2-piperidin-2-ylacetate; Methyl alpha-phenyl-alpha-(2-piperidyl)acetate; Methyl alpha-phenyl-alpha-2-piperidinylacetate; Methyl phenidate; Methyl phenidyl acetate; Methyl phenidylacetate; Methyl phenyl(piperidin-2-yl)acetate; Methylfenidan; Methylin; Methylin (TN); Methylin ER; Methylofenidan; Methylphen; Methylphenidan; Methylphenidate (USAN/INN); Methylphenidate [INN:BAN]; Methylphenidatum; Methylphenidatum [INN-Latin]; Metilfenidato; Metilfenidato [INN-Spanish]; Metilfenidato [Italian]; Motiron (TN); PMS-Methylphenidate; Phenidylate; Plimasine; Riphenidate; Ritalin; Ritalin (TN); Ritalin LA; Ritalin LA (TN); Ritalin SR; Ritalin-SR; Ritaline; Ritcher works; Rubifen (TN); Tsentedrin
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Traumatic brain injury [ICD11: NA07.Z] | Approved | [1] | |||
| Therapeutic Class |
Central Nervous System Stimulants
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C14H19NO2
|
|||||
| Canonical SMILES |
COC(=O)C(C1CCCCN1)C2=CC=CC=C2
|
|||||
| InChI |
InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3
|
|||||
| InChIKey |
DUGOZIWVEXMGBE-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 113-45-1
|
|||||
| Pharmaceutical Properties | Molecular Weight | 233.31 | Topological Polar Surface Area | 38.3 | ||
| Heavy Atom Count | 17 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
0.2
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103209574
, 103858000
, 103958410
, 104305599
, 10504398
, 124954808
, 127787857
, 134337354
, 134974024
, 135709935
, 136897384
, 137007933
, 142361369
, 14798219
, 160963768
, 163411030
, 178103810
, 179148478
, 216106193
, 223897828
, 226423048
, 249807024
, 249948308
, 252404612
, 26746622
, 29223265
, 46505929
, 47206727
, 48416258
, 49854760
, 5336253
, 53789341
, 57322165
, 78286794
, 7979945
, 8152600
, 85209963
, 9405
|
|||||
| ChEBI ID |
ChEBI:84276
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | GLYT2 | Transporter Info | Sodium- and chloride-dependent glycine transporter 2 | Substrate | [2] | |
| References | ||||||
| 1 | Methylphenidate was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | SLC6 transporters: structure, function, regulation, disease association and therapeutics. Mol Aspects Med. 2013 Apr-Jun;34(2-3):197-219. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.